| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,169 |
2,750 |
$774K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,447 |
1,208 |
$499K |
| 80053 |
Comprehensive metabolic panel |
4,126 |
3,594 |
$173K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
287 |
229 |
$104K |
| 87081 |
|
3,066 |
2,992 |
$81K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,026 |
2,550 |
$63K |
| 36415 |
Collection of venous blood by venipuncture |
4,448 |
3,854 |
$51K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
282 |
277 |
$35K |
| 86140 |
|
998 |
880 |
$23K |
| 84443 |
Thyroid stimulating hormone (TSH) |
558 |
513 |
$23K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
146 |
137 |
$22K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
183 |
145 |
$21K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
110 |
78 |
$12K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
423 |
405 |
$11K |
| 80061 |
Lipid panel |
169 |
169 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
169 |
140 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
160 |
149 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
256 |
133 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
99 |
84 |
$5K |
| 85027 |
|
264 |
243 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
52 |
40 |
$3K |
| 84484 |
|
280 |
212 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
51 |
39 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
176 |
135 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
73 |
72 |
$2K |
| 87070 |
|
60 |
58 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
16 |
12 |
$2K |
| 80305 |
|
64 |
56 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
206 |
203 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
151 |
132 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
17 |
16 |
$1K |
| 83690 |
|
56 |
42 |
$1K |
| 82550 |
|
70 |
65 |
$973.69 |
| 87400 |
|
14 |
12 |
$938.42 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$869.82 |
| 71045 |
Radiologic examination, chest; single view |
25 |
24 |
$796.84 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$587.22 |
| 83605 |
|
18 |
15 |
$569.91 |
| 85610 |
|
77 |
67 |
$522.12 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
29 |
25 |
$439.56 |
| 81001 |
|
41 |
29 |
$371.29 |
| 81003 |
|
80 |
67 |
$365.44 |
| 83735 |
|
39 |
37 |
$326.26 |
| 94664 |
|
16 |
12 |
$298.70 |
| 85007 |
|
14 |
12 |
$244.14 |
| 85379 |
|
14 |
12 |
$209.24 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16 |
14 |
$126.01 |